Avelumab vs Standard Second-Line Chemotherapy for Metastatic Colorectal Cancer With Microsatellite Instability
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
JAMA Oncol 2023 Aug 03;[EPub Ahead of Print], J Taïeb, O Bouche, T André, K Le Malicot, P Laurent-Puig, J Bez, C Toullec, C Borg, V Randrian, L Evesque, S Corbinais, H Perrier, B Buecher, F Di Fiore, C Gallois, JF Emile, C Lepage, F Elhajbi, D TougeronFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.